Clinical trial
Androgen Deprivation Withdrawal Versus Maintenance and Intermittent Chemotherapy Versus Continuous in Prostate Cancer Patients With Castrate Resistant Disease
NCT01224405 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Androgen Deprivation Withdrawal Versus Maintenance and Intermittent Chemotherapy Versus Continuous in Prostate Cancer Patients With Castrate Resistant Disease
- Lead sponsor
- University of Turin, Italy
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2010
- Completion date
- April 30, 2016
- Enrollment
- 600 (estimated)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
advanced prostate cancer